相关实验视频

Updated: Jul 26, 2025

Large-Scale SARS-CoV-2 Testing Utilizing Saliva and Transposition Sample Pooling

Large-Scale SARS-CoV-2 Testing Utilizing Saliva and Transposition Sample Pooling

Published on: June 23, 2022

数字PCR在SARS-CoV-2的Omicron变体和免疫逃生突变之间进行歧视

Steven C Holland¹, LaRinda A Holland¹, Matthew F Smith¹

¹Center for Fundamental and Applied Microbiomics, Biodesign Institute, Arizona State University, Tempe, Arizona, USA.

Microbiology spectrum

|June 12, 2023

概括

数字PCR (dPCR) 试验可以识别SARS-CoV-2突变,帮助个性化治疗. 这项研究表明dPCRR.

科学领域:

病毒学病毒学
分子诊断学分子诊断
基因组学就是基因组学.

背景情况:

严重急性呼吸道综合征冠状病毒2 (SARS-CoV-2) 演变,导致免疫逃避和治疗耐药性.
准确识别病毒突变对于指导个性化的患者治疗计划至关重要.
数字PCR (dPCR) 提供了一种快速可靠的方法来检测单核酸多态 (SNP).

研究的目的:

开发和验证一组SARS-CoV-2dPCR试验小组.
证明这些测试用于变异系型和检测与治疗耐药性相关的突变的应用.
评估dPCR作为指导患者治疗的个性化诊断工具的实用性.

主要方法:

设计了多重复合dPCR测定,针对orf1ab基因中的SNP,以区分SARS-CoV-2Delta,Omicron BA.1和BA.2系.
开发了针对关键尖端突变 (R346T,K444T,N460K,F486V,F486S) 的dPCR试验,这些突变与免疫逃避和减少单克隆抗体有效性有关.
在临床唾液样本上使用Illumina全基因组测序进行验证的验证分析.

主要成果:

在596个临床标本上使用dPCR测定成功分化了Delta,Omicron BA.1和BA.2系.
在81个临床标本上使用dPCR识别了Omicron亚型 (BA.2.75.2,BM.1.1,BN.1,BF.7,BQ.1,BQ.1.1,XBB) 的特定突变.
证明了多重测试的能力,可以同时检测多达4个SNP.

结论:

数字PCR测定对于类型化SARS-CoV-2变种血统和检测赋予治疗耐药性的突变是有效的.
dPCR是全基因组测序的宝贵补充,用于快速病毒基因型定型.
这些发现支持使用dPCR作为个性化诊断工具,以告知SARS-CoV-2治疗决策.

关键词:

这就是SARS-CoV-2病毒.临床诊断临床诊断临床诊断数字PCR是数字的PCR.免疫逃生突变的突变这是一种单克隆抗体.

更多相关视频

Two-Step Reverse Transcription Droplet Digital PCR Protocols for SARS-CoV-2 Detection and Quantification

Two-Step Reverse Transcription Droplet Digital PCR Protocols for SARS-CoV-2 Detection and Quantification

Published on: March 31, 2021

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19

Published on: February 16, 2022

相关概念视频

Single Nucleotide Polymorphisms-SNPs

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...